Penetration force, geometry, and cutting profile of the novel and old ozurdex needle: The MONO study

Journal of Ocular Pharmacology and Therapeutics

Volumn 30, Issue 5, 2014, Pages 387-391

  Meyer, Carsten H ^a,b   Liu, Zengping ^b,c   Brinkmann, Christian K ^b   Rodrigues, Eduardo B ^d   Bertelmann, Thomas ^e  

^a Pallas Clinic   (Switzerland)

^b UNIVERSITY OF BONN   (Germany)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; POLYURETHAN;

ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; FORCE; GEOMETRY; MEASUREMENT; NEEDLE; OPHTHALMIC DRUG DELIVERY DEVICE; RETINA MACULA EDEMA; SCLERA; TRANSCONJUNCTIVAL DRUG ADMINISTRATION; DEVICES; EQUIPMENT DESIGN; INJECTION; STANDARDS;

DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; INJECTIONS; NEEDLES;

EID: 84902130796     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0231     Document Type: Article

References (19)

1. Haller, J.A., Bandello, F., Belfort, Jr., R., Blumenkranz, M.S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y.H., Jacques, M.L., Jiao, J., Li, X.Y., and Whitcup, S.M.; OZURDEX GENEVA Study Group. Randomized, shamcontrolled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 117:1134-1146, 2010
2. Lang, G.E. Diabetic macular edema. Ophthalmologica. 227 Suppl 1:21-29, 2012
3. Callanan, D.G., Gupta, S., Boyer, D.S., Ciulla, T.A., Singer, M.A., Kuppermann, B.D., Liu, C.C., Li, X.Y., Hollander, D.A., Schiffman, R.M., and Whitcup, S.M.; Ozurdex PLACID Study Group. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology. 120:1843-1851, 2013
4. Querques, L., Querques, G., Lattanzio, R., Gigante, S.R., Del Turco, C., Corradetti, G., Cascavilla, M.L., and Bandello, F. Repeated intravitreal dexamethasone implant (Ozurdex-) for retinal vein occlusion. Ophthalmologica. 229:21-25, 2013
5. Guignier, B., Subilia-Guignier, A., Fournier, I., Ballonzoli, L., Speeg-Schatz, C., and Gaucher, D. Prospective pilot study: Efficacy of intravitreal dexamethasone and bevacizumab injections in the treatment of macular oedema associated with branch retinal vein occlusion. Ophthalmologica. 230:43-49, 2013
6. Bezatis, A., Spital, G., Höhn, F., Maier, M., Clemens, C.R., Wachtlin, J., Lehmann, F., Hattenbach, L.O., and Feltgen, N. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: A 6-month follow-up-The SOLO study. Acta Ophthalmol. 91:340-347, 2013
7. Meyer, C.H., Klein, A., Alten, F., Liu, Z., Stanzel, B.V., Helb, H.M., and Brinkmann, C.K. Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: Kinematic analysis with a high-speed camera. Retina. 32:2133-2140, 2012
8. Khurana, R.N., Appa, S.N., McCannel, C.A., Elman, M.J., Wittenberg, S.E., Parks, D.J., Ahmad, S., and Yeh, S. Dexamethasone implant anterior chamber migration: Risk factors, complications, and management strategies. Ophthalmology. 121:67-71, 2014
9. Schmitz, K., Maier, M., Clemens, C.R., Höhn, F., Wachtlin, J., Lehmann, F., Bertelmann, T., Feltgen, N., and Bezatis, A. Reliability and safety of intravitreal Ozurdex injections: The ZERO study. Ophthalmologe. 111:44-52, 2014
10. Meyer, C.H., Kaymak, H., Liu, Z., Saxena, S., and Rodrigues, E.B. Geometry, penetration force and cutting profile of different 23-gauge trocars systems for pars-plana vitrectomy. Retina. [In press].
11. Pallikaris, I.G., Kymionis, G.D., Ginis, H.S., HS, Kounis, G.A., and Tsilimbaris, M.K. Ocular rigidity in living human eyes. Invest. Ophthalmol. Vis. Sci. 46:409-414, 2005
12. Meyer, C.H., Krohne, T.U., Chabrel Issa, P., and Holz, F.G. Routes for drug delivery to the eye and retina: Intravitreal injections and vitrectomy, Chapter 12. In: Nguyen, Q.D., Rodrigues, E.B., Farah, M.E., and Mieler, W.F., eds. Retinal Pharmacotherapy. Elsevier Publications New York, USA; 2009; pp. 67-73
13. Meyer CH, Michels, S., Rodrigues, E.B., Hager, A., Mennel, S., Schmidt, J.C., Helb, H.M., and Farah, M.E. Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections. Acta Ophthalmol. 89:70-75, 2011
14. Rodrigues, E.B., Meyer, C.H., Grumann, Jr., A., Shiroma, H., Aguni, J.S., and Farah, M.E. Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am. J. Ophthalmol. 143:1035-1037, 2007
15. Haller, J.A., Dugel, P., Weinberg, D.V., Chou, C., and Whitcup, S.M. Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema. Retina. 29:46-51, 2009
16. Kozak, I., Dean, A., Clark, T.M., Falkenstein, I., and Freeman, W.R. Prefilled syringe needles versus standard removable needles for intravitreous injection. Retina. 26:679-683, 2006
17. Mayer, W.J., Remy, M., Wolf, A., Kook, D., Kampik, A., Ulbig, M., Reznicek, L., and Haritoglou, C. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Ophthalmologica. 228:110-116, 2012
18. Noma, H., Funatsu, H.,Mimura, T., Eguchi, S., and Shimada, K. Inflammatory factors in major and macular branch retinal vein occlusion. Ophthalmologica. 227:146-152, 2012
19. Zucchiatti, I., Lattanzio, R., Querques, G., Querques, L., Del Turco, C., Cascavilla, M.L., and Bandello, F. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica. 228:117-122, 2012.